Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
BME
02:35:16 10/10/26 am AEDT
|
After hours 06:58:31 am | |||
| 58.05 EUR | -0.17% |
|
58.20 | +0.26% |
| 05/10 | Spanish stocks - Factors to watch on Oct 5 | RE |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 2.97B 3.33B 2.77B 2.52B 4.75B 322B 4.77B 33.3B 13.05B 164B 12.5B 12.23B 527B | P/E 2026 * |
19.6x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 2.97B 3.32B 2.76B 2.51B 4.74B 321B 4.76B 33.2B 13.01B 164B 12.47B 12.2B 526B | EV / Sales 2026 * |
3.83x | EV / Sales 2027 * | 3.25x |
| Free-Float |
31.63% | Yield 2026 * |
1.67% | Yield 2027 * | 2% |
| Markets | Quality | ||
|---|---|---|---|
BME
| ROVI | Delayed | |
CBOE
| ROVIe | Real-time | |
|
Tradegate
| 41L | Real-time | |
|
OTC Markets
| LABFF | Delayed | |
|
Boerse Muenchen
| 41L | Real-time | |
|
Deutsche Boerse AG
| 41L | Delayed | |
|
CBOE
| 0ILL | Real-time | |
|
Börse Stuttgart
| 41L | Delayed | |
|
Wiener Boerse
| ROVI | End-of-day quote | |
|
Borsa Italiana
| 1ROVI | End-of-day quote |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | +0.09% | ||
| 1 week | +1.13% | ||
| Current month | -1.28% | ||
| 1 month | +0.61% | ||
| 3 months | +3.38% | ||
| 6 months | -29.59% | ||
| Current year | -8.58% |
| 1 week | 56.85 |  | 59.3 |
| 1 month | 56.55 | | 60.7 |
| Current year | 53.1 | | 86.7 |
| 1 year | 53.1 | | 86.7 |
| 3 years | 45.52 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 23/6/23 | Buy | Director | 1,000 | 0.0019% | ||
| 13/4/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 15/3/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | +1.13% | 0.00% | +9.74% | 3.33B | |
| +0.59% | +2.91% | +37.50% | +105.70% | 1,043B | |
| +1.70% | +1.90% | +36.53% | +64.56% | 618B | |
| -0.40% | +5.09% | +19.73% | +85.24% | 481B | |
| +2.51% | +1.23% | +66.94% | +39.78% | 351B | |
| +1.45% | +3.50% | +21.87% | +42.64% | 338B | |
| +1.17% | +2.37% | +11.71% | +35.14% | 269B | |
| +0.89% | +1.08% | -7.28% | +10.52% | 244B | |
| +1.80% | +3.31% | +40.94% | +53.34% | 220B | |
| +2.77% | +4.35% | +29.38% | +101.22% | 182B | |
| Average | +1.40% | +0.39% | +25.73% | +54.79% | 375B | |
| Weighted average by Cap. | +1.25% | +0.60% | +31.42% | +69.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 867M 720M 655M 1.24B 83.88B 1.24B 8.67B 3.4B 42.77B 3.25B 3.18B 137B | 892M 999M 830M 755M 1.43B 96.71B 1.43B 9.99B 3.91B 49.3B 3.75B 3.67B 158B |
| Net income | 146M 164M 136M 124M 234M 15.85B 235M 1.64B 642M 8.08B 615M 601M 25.93B | 173M 194M 161M 146M 276M 18.73B 277M 1.94B 758M 9.55B 727M 711M 30.65B |
| Net Debt | -8.5M -9.52M -7.91M -7.19M -13.58M -921M -13.64M -95.16M -37.29M -470M -35.74M -34.96M -1.51B | -72.51M -81.19M -67.45M -61.35M -116M -7.86B -116M -812M -318M -4.01B -305M -298M -12.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/10/26 | EUR 58.05 | -0.17% | 56,180 |
| 08/10/26 | EUR 58.15 | -1.44% | 120,294 |
| 07/10/26 | EUR 59.00 | +1.46% | 100,493 |
| 06/10/26 | EUR 58.15 | +1.93% | 90,765 |
| 05/10/26 | EUR 57.05 | -0.61% | 63,136 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
